Figure (Atorvastatin Calcium Figure 1)
Atorvastatin Calcium
Product Images NDC 53002-2439
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-2439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Atorvastatin Calcium Figure 2)
This appears to be a graph or table showing the cumulative hazard percentage for a placebo and a drug called Atorvastatin. The drug is associated with a lower hazard than the placebo, as evidenced by the hazard ratio of 0.63 with a p-value of 0.001. The x-axis represents time (in years) up to the first primary endpoint, while the y-axis shows the cumulative hazard percentage.*
Figure (Atorvastatin Calcium Figure 3)
This is a summary of a study on Atorvastatin, a medication used to lower cholesterol levels, and its effects on major cardiovascular events. The text shows a graph with four points marking the time it took for patients to experience a major cardiovascular event, and two percentages indicating the incidence of the events on two different doses of the medication. The study found that the higher dose of Atorvastatin was associated with a lower risk of experiencing a major cardiovascular event, with a hazard ratio of 0.78 and a p-value of 0.0002.*
Chemical Structure (Atorvastatin Calcium Structure)
Label Image (Lbl530022439)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
